Cardiotoxicity and Risk Factors in Patients With Colorectal Cancer Receiving Fluoropyrimidine
NCT02665312
Observational
Unknown status
observational prospective study, designed for patients with colorectal cancer receiving for the first time 5-FU or capecitabine, with or without other chemotherapy combinations.
Jan 31,2016
All
18 Years
N/A
18 Years
N/A
200